NEWS & EVENTS

Latest news and upcoming events

Memo Therapeutics increases Series C financing to CHF 45 million
07 May 2024

Memo Therapeutics increases Series C financing to CHF 45 million

Upcoming events

  • Bio€quity Europe
    14 - 16 May 2024,
    San Sebastián

    download

  • AseBio Investor Day 2024
    15 May 2024,
    San Sebastián

    download

  • ESMO Congress 2024
    13 - 19 September 2024,
    Barcelona

    download
Paula Olazábal joins Ysios Capital Partners as investment manager<
22 Jul 2008

Paula Olazábal joins Ysios Capital Partners as investment manager

Her appointment comes along with the new stage of the venture capital firm specialized in biotech, which is preparing the first closing of Ysios BioFund I.
Ysios Capital Partners names Marc Casellas as Chief Financial Officer<
09 Jul 2008

Ysios Capital Partners names Marc Casellas as Chief Financial Officer

Ysios has created this position to manage the increased activity expected as the initial capital subscription of its first fund, Ysios BioFund I, draws to a close
Ysios Capital Partners announces the imminent first closing of the largest Spanish venture capital fund in the biotech sector<
10 Mar 2008

Ysios Capital Partners announces the imminent first closing of the largest Spanish venture capital fund in the biotech sector

The company anticipates a first closing of around EUR 60 million in brief.
20 Sep 2007

Ysios co-leads €27,2million Series B financing of stem cell company Cellerix

Barcelona, September 20, 2007. ‐ Cellerix, a biopharmaceutical company leader in the clinical development and production of innovative medicines based on adult stem cells, has closed an oversubscribed Series B financing round for €27.2M.
Ysios co-leads €27,2million Series B financing of stem cell company Cellerix<
20 Sep 2007

Ysios co-leads €27,2million Series B financing of stem cell company Cellerix

The round was led by two of the most experienced life science investors in Europe, LSP (Netherlands) and Ventech (France).
Ysios Capital Partners Starts Registration as an Independent Biotech Venture Capital Firm in Spain<
13 Sep 2007

Ysios Capital Partners Starts Registration as an Independent Biotech Venture Capital Firm in Spain

Ysios Capital Partners will be raising €65 million for their first fund, Ysios BioFund I.

Newsletter

subscribe

Subscribe to our weekly newsletter for the latest
updates on life sciences investments.

Bitplex 360 Кракен даркнет кракен даркнет Blacksprut Blacksprut Кракен ссылка кракен ссылка